Daniel Gordon Kirby
Chief Commercial Officer at Iovance Biotherapeutics · 7 reported transactions in 1 company · latest trade Jun 5, 2025
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +37.8%, S&P 500 +13.8% over the same days.
Their trades
Bought | Jun 5, 2025 | Jun 5, 2025 close $1.80 → Oct 29, 2026 close $9.56. S&P 500 +30.2% over the same days. |
BoughtIovance Biotherapeutics
$55.2K
Jun 5, 2025 close $1.80 → Oct 29, 2026 close $9.56. S&P 500 +30.2% over the same days.